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Abstract
Objective: This study tested clinical utility of the DSM-5 severity specifier for bulimia nervosa
(BN) in predicting treatment response among adolescents (N = 110) within a randomized clinical
trial of two psychosocial treatments.
Method: Analyses grouped individuals meeting criteria for BN diagnosis by baseline severity,
per DSM-5. Associations among baseline severity classification and BN behavior (i.e., binge eat-
ing and compensatory behavior) and eating disorder examination (EDE) Global scores at end-of-
treatment (EOT), 6- and 12-month follow-up were examined.
Results: Associations between severity categories with BN symptoms were not significant at
EOT, or follow-up. Test for linear trend in BN behavior was significant at EOT, F = 5.23, p = 0.02,
without demonstrating a linear pattern. Relation between severity categories with EDE Global
scores was significant at 6-month follow-up, F = 3.76, p = 0.01. Tests for linear trend in EDE
Global scores were significant at EOT, F = 5.40, p = 0.02, and at 6 months, F = 10.73, p = 0.002,
with the expected linear pattern.
Discussion: Findings suggest the DSM-5 BN severity specifier holds questionable utility in antic-
ipating outpatient treatment response in adolescents with BN. The specifier may have improved
ability to predict attitudinal rather than behavioral treatment outcomes.
KEYWORDS
adolescents, bulimia nervosa, cognitive behavioral therapy, family-based treatment, severity
classification, treatment outcome
1 | INTRODUCTION
Bulimia nervosa (BN) is a disabling eating disorder (ED) characterized
by episodes of binge eating and compensatory behavior with concom-
itant overvaluation of weight and shape. BN often begins in adoles-
cence though there is limited research evaluating treatment outcomes
in this demographic (Le Grange, Loeb, Van Orman, & Jellar, 2004). To
aid in improved diagnosis of BN, the fifth edition of the Diagnostic and
Statistical Manual for Mental Disorders (DSM-5; American Psychiatric
Association (APA), 2013) eliminated prior purging- and non-purging
subtypes of BN, and also introduced severity specifiers. The severity
classifications are based on the frequency of compensatory behaviors
(i.e., self-induced vomiting, laxative, diuretic, medication misuse, fast-
ing, or excessive exercise), according to average episodes per week:
mild (1–3), moderate (4–7), severe (8–13), and extreme (≥14).
Introduction of severity ratings across diagnoses was intended to aid
clinicians in identifying gradients of a disorder that may not be fully cap-
tured by strict categorical approaches (Regier, Kuhl, & Kupfer, 2013), and
to provide information regarding associated risks and prognosis (Gianini
et al., 2017). Initial tests of DSM-5 specifiers in adult samples with BN
indicated significant differences between severity categories (Dakanalis
et al., 2017) but somework has indicated small effect sizes, and only mod-
est support for their utility in adult samples (Grilo, Ivezaj, & White, 2015).
The specifiers have recently been tested in youth to determine valid dif-
ferences among categories (Dakanalis et al., 2018). In this sample, support
was evidenced for the severity indicator, such that individuals in the
“extreme” group reported significantly higher levels of ED pathology at
initial evaluation. Given uncertainty regarding the robustness of severity
specifiers in adult samples with BN, and the paucity of their investigation
specifically in youth, further investigation of the specifiers is warranted.
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The goal of evidence-based treatments (EBTs) for BN is to inter-
rupt patterns of dieting, binge eating and compensatory behavior,
with the ultimate goal of abstinence from these symptoms. Within BN
treatment, behavioral symptoms (e.g., binge eating, purging) typically
remit prior to attitudinal symptoms (e.g., undue influence of body
shape and weight on self-evaluation; Ciao, Accurso, Fitzsimmons-
Craft, & Le Grange, 2015). Both mitigation of behavioral symptoms
and attitudinal features are important indicators of recovery
(e.g., Halmi et al., 2002), and thus represent BN treatment goals.
Improved prediction of treatment response is critical to guiding inter-
vention and in creating realistic expectations for patients, families, and
providers alike. To this end, severity classification at baseline may
offer clinical utility in predicting response to EBT for BN in adoles-
cents, a relation not examined to date.
1.1 | Current study
Analyses were secondary, implemented specifically to investigate out-
comes related to eating pathology. The current study examined asso-
ciations between severity specifier categories and attitudinal
(i.e., cognitive and psychological) symptoms of BN at end-of-
treatment (EOT), and at 6- and 12-month follow-up. We also exam-
ined associations between severity specifier categories and rates of
binge eating and compensatory behavior at all three time points. As
secondary aims, analyses compared (a) rates of abstinence from binge
eating and compensatory behavior and (b) rates of binge eating behav-
ior (i.e., a composite of subjective and objective binge eating) between
baseline severity categories. Of note, adolescents in the current sam-
ple received either family-based treatment for BN (FBT-BN) or cogni-
tive behavior therapy adapted for adolescents (CBT-A). Although
adolescents treated in FBT-BN were significantly more likely to
achieve abstinence from BN symptoms at EOT, both groups contin-
ued to improve over the year following EOT with no significant differ-
ences in outcome at 12-month follow-up (Le Grange, Lock, Agras,
Bryson, & Jo, 2015). In this secondary data analysis of the original
RCT, and testing across the combined sample, we hypothesized that
those with elevated baseline severity would be more likely to demon-
strate greater symptomatology at EOT and extended follow-up, both
attitudinally and behaviorally.
2 | METHOD
2.1 | Participants and procedure
A detailed description of the study sample can be found in the main
outcome report (c.f., Le Grange et al., 2015). Briefly, participants
(N = 110; 93.6% female) aged 12–18 from two sites who met DSM-
IV criteria for BN or BN-type ED not otherwise specified (APA, 2000)
were randomized to one of two active treatment types, CBT-A
(n = 58) or FBT-BN (n = 52). Diagnoses and ED symptom report were
determined by eating disorder examination (EDE; Cooper & Fairburn,
1987) interview. Institutional review boards at all participating institu-
tions approved study protocols, and all participants provided informed
consent or assent (in the case of minors) prior to participation.
2.2 | Analytical plan
Reported BN behaviors (i.e., binge eating; self-induced vomiting; misuse
of laxatives, diuretics or medication; excessive exercise; fasting) over
the past 3 months were tallied and divided by 12 to produce a weekly
average, which was used to confirm DSM-5 diagnosis. Based on symp-
tom report of compensatory behaviors from baseline EDE interview
and DSM-5 classification criteria, participants were then classified into
one of four categories: “mild,” “moderate,” “severe,” and “extreme.” The
attitudinal outcome was determined as EDE Global score (i.e., mean of
the four subscales) at EOT, 6- and 12-month follow-up. Also tested at
all three time points, the behavioral outcome (i.e., composite of binge
eating and compensatory behaviors) was based on report of symptoms
in the prior month. To compare the two outcomes across categories, a
general linear model was used to test for differences by severity. A lin-
ear contrast was estimated to test for a linear trend in each model. Lin-
ear trend estimation is a statistical technique that can be used to aid in
the interpretation of categorical data. Specifically, trend estimation was
used in the current study to determine if our categorical data exhibited
an increasing or decreasing trend, in a manner statistically distinguished
from random behavior. Secondary analyses tested relations between
baseline severity categories and abstinence from binge eating and com-
pensatory behavior, as well as relations between baseline severity cate-
gories and binge eating behavior, across all measured time points.
Significance was determined with p values of <0.05, and Cohen's f2
(small: 0.1; medium: 0.25; large: 0.4) was used to benchmark effect
sizes, based on variance explained by eta, and partial eta squared. SAS
v9.4 was used for all analyses.
3 | RESULTS
3.1 | Descriptive statistics
This report focused on pretreatment severity specifiers and associa-
tions with attitudinal (i.e., EDE Global scores) and behavioral indica-
tors of BN recovery (i.e., binge eating and compensatory behavior). At
baseline, all participants met DSM-5 diagnosis for BN; 17 (15.45%)
individuals were classified as mild, 32 (29.09%) moderate, 37 (33.64%)
severe, and 24 (21.82%) extreme regarding severity specifiers.
3.2 | Primary analyses
As the outcome measure of BN behavior was skewed, a log-
transformed version was calculated. Results were largely unchanged
for the nontransformed data; accordingly, the original scale for both
outcomes is reported for ease of interpretation (Table 1).
3.2.1 | Behavioral outcome
Tests of a behavioral model of outcome as a continuous variable
(i.e., number of BN behaviors) did not indicate significance in the full
model at EOT, or 6- and 12-month follow-up. The test for trend for
the outcome was statistically significant at EOT, F = 5.23, p = 0.02,
ωp
2 = 0.06, 95% CI [0, 0.18], with a small-medium effect size, but did
not follow a linear pattern and did not yield differences as we might
expect at the extremes of the distribution (Figure 1). Specifically,
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means of BN behavior at EOT were higher in the “mild” category than
for “moderate.” And while means for “moderate” were lower than for
“severe,” means for “extreme” were lower than for “severe.” Linear
trends were not significant for either the 6- or 12-month follow-ups.
3.2.2 | Attitudinal outcome
Tests of the attitudinal model for outcome (i.e., EDE Global scores) did
not indicate significance in the full model at EOT, but test for trend
was significant, F = 5.40, p = 0.02, ωp
2 = 0.06, 95% CI [0, 0.17], with
a medium effect size. This trend demonstrated a pattern of increasing
means at EOT according to increase in severity category at baseline.
The full model for 6-month follow-up was significant, F = 3.76,
p = 0.01, ωp
2 = 0.15, 95% CI [0.01, 0.27], and also demonstrated a
significant trend, F = 10.73, p = 0.002, ωp
2 = 0.14, 95% CI [0.02,
0.29], both of which evidenced large effect sizes. As with the EOT
model, this trend also demonstrated a pattern of increasing means at
6-month follow-up according to increase in severity category at
baseline. Neither the full model, nor the trend, demonstrated signifi-
cance at 12-month follow-up.
3.3 | Secondary analyses
3.3.1 | Abstinence from binge eating and compensatory
behaviors
Tests of the relation between baseline severity category and absti-
nence (i.e., cessation from a combination of binge eating and compen-
satory behaviors) were not significant at EOT, or 6-month follow-up.
The abstinence model demonstrated significant outcomes at
12-month follow-up, χ2 = 0.02.
3.3.2 | Binge eating
Tests of the relation between severity category and binge eating
behavior (i.e., combined subjective and objective binge eating episodes)
did not indicate significant outcomes across measured time points.
TABLE 1 General linear model regression for behavioral and attitudinal outcomes
Model M (SD) Median FFull (df) pFull ω
2 CIFull FTrend (df) pTrend ωp
2 CITrend
BN behavior
N = 86 EOT 19.05 (34.79) 7.00 2.26 (3) 0.09 0.08 [0, 0.18] 5.23 (1) 0.02 0.06 [0, 0.18]
N = 68 6-month 19.06 (31.86) 6.50 2.01 (3) 0.12 0.09 [0, 0.20] 3.96 (1) 0.05 0.06 [0, 0.19]
N = 70 12-month 15.20 (24.91) 2.00 1.19 (3) 0.32 0.05 [0, 0.15] 1.63 (1) 0.21 0.02 [0, 0.13]
EDE global
N = 93 EOT 1.82 (1.46) 1.50 1.95 (3) 0.13 0.03 [0, 0.15] 5.40 (1) 0.02 0.06 [0, 0.17]
N = 70 6-month 1.55 (1.39) 1.22 3.76 (3) 0.01 0.15 [0.01, 0.27] 10.73 (1) 0.002* 0.14 [0.02, 0.29]
N = 71 12-month 1.30 (1.17) 0.86 2.02 (3) 0.12 0.08 [0, 0.20] 3.01 (1) 0.09 0.04 [0, 0.16]
Note. BN = bulimia nervosa; EOT = end-of-treatment; Subscripts full and trend reflect values correspondent to each model.
Bold values are significant at p < 0.05; bold values with *asterisk indicates p < 0.01.
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FIGURE 1 Behavioral outcomes and EDE global scores according to baseline severity.
Note. EDE = eating disorder examination; Columns depict results for end-of-treatment, 6- and 12-month follow-up, respectively [Color figure can
be viewed at wileyonlinelibrary.com]
588 GORRELL ET AL.
4 | DISCUSSION
This study sought to examine the predictive utility of pretreatment
severity classification on both behavioral and attitudinal markers of
treatment outcome in adolescents receiving outpatient treatment for
BN within the context of a randomized clinical trial. Results of this
study indicate that when considering attitudinal status following treat-
ment, adolescents presenting to treatment with mild baseline severity
reported fewer symptoms of ED pathology at EOT, with a linear trend
indicating that with each advance in clinical severity category at base-
line, we might expect a correspondent elevation in attitudinal ED
pathology at EOT. In contrast, those who endorsed the lowest fre-
quency of compensatory behavior at baseline (i.e., mild) were not nec-
essarily more likely to demonstrate the lowest number of BN
behaviors at EOT. In particular, the clinical utility of the severity speci-
fier appeared to perform poorly at either end of the scale, in the ‘mild’
and “extreme” categories. At 6-month follow-up, those who demon-
strated elevated severity at baseline were significantly more likely to
also endorse elevated scores on attitudinal symptoms of BN, with a
trend that was significant and in the increasing pattern that we might
expect (i.e., those with the greatest severity at baseline were also the
most symptomatic at follow-up). Both the full model and the trend of
attitudinal outcomes at 6-months demonstrated large effect sizes; this
is in contrast to the medium and small-medium effect sizes demon-
strated by the trends in attitudinal and behavioral outcome, respec-
tively, at EOT. Of note, neither the full model for attitudinal or
behavioral symptoms, nor tests for trend, were significant at
12-month follow-up, bringing into question the utility of the specifiers
in predicating longer-term outcomes.
When considering the behavioral outcome variable as categorical
(i.e., abstinence), baseline severity categories only significantly pre-
dicted rates of abstinence from binge eating and compensatory
behavior at 12-month follow-up. Further, the current study did not
indicate differences in the severity categories in predicting rates of
binge eating behavior. These models favoring categorial outcomes did
not consistently bear out significant results, but depending on context,
reduction in a symptom may hold more clinical meaning than simply
its presence versus absence. For instance, it may be that an individual
had engaged in purging only once in the prior month, as compared to
daily at baseline; while standards of remission might favor abstinence
from purging at EOT, this reduction would certainly constitute a clini-
cally meaningful result of treatment.
There are several possible explanations for our findings. Large-
scale treatment trials for BN have indicated that there are differences
in the rate at which behavioral symptoms subside, relative to attitudi-
nal symptoms (e.g., Ciao et al., 2015). Results from the current study
confirm this general finding, and suggest that there are other factors
that influence more rapid behavioral change within the context of
psychosocial treatment, other than simply baseline severity. One such
factor could be motivation for change. While research on motivation
within the context of ED treatment does not demonstrate consistency
in improved outcomes directly related to motivation (Waller, 2012), it
is possible that variable motivation throughout treatment contributed
to the inconsistencies in behavioral outcomes at EOT evidenced in
the current study.
Other possible explanations for the current findings include the
nature and size of the sample. The ability of the severity specifiers to
predict behavioral outcomes at EOT was the least effective within the
extremes of the distribution, specifically for the “mild” and “extreme”
categories. It is possible that our findings are reflective of inadequate
power in a sample size that is not sufficient to detect differences
between categories. It is also possible that the DSM-5 criteria for each
category (e.g., ≥14 symptoms corresponds to “extreme”) allows for
potentially exaggerated variability in classification, as one individual
reporting 15 symptoms per week was considered categorically equiva-
lent to another with 264. When considering the “mild” category, one
such individual may be self-inducing vomiting three times per week,
whereas another might be engaging in fasting twice per week, and
driven exercise once per week. While this is a hypothetical example,
we might assume that the individual who is vomiting regularly at base-
line may have different treatment outcomes than the individual with
fasting and exercise behavior. The current study lacked power to
examine specific patterns of behavior within classification categories
(e.g., differences between those who self-induce vomiting vs. other
types of compensatory behavior), and further investigation is
warranted.
The ability to use baseline presentation to predict outcome would
aid clinicians, parents, and patients in understanding who might bene-
fit most from existing EBT approaches, and potentially inform future
efforts to increase precision medicine decisions in ED treatment. It
should be noted that clinicians are not bound strictly to these severity
cut-offs, the level of which may be increased to reflect functional dis-
ability and other clinically meaningful sequelae (APA, 2013). However,
as the current study did not demonstrate the clinical utility of baseline
severity in predicting behavioral outcomes following treatment, fur-
ther directions might include examining how baseline severity predicts
treatment outcome amongst a subset of individuals who achieve rapid
symptom reduction. Significant results may be effective in planning
and adapting treatment course.
Findings suggest that there may be utility to determining DSM-5
severity classification prior to the start of treatment to predict attitu-
dinal response following treatment. Specifically, adolescents who
endorse a minimum average of 14 symptomatic episodes per week in
the 3-months prior to treatment, and considered “extreme,” will likely
continue to report the greatest elevations in EDE Global scores at
EOT, and at 6-month follow-up. Therefore, evaluating severity classifi-
cation at treatment outset may aid in identifying those adolescents
who are most likely to require an extended or augmented approach to
existing EBTs. Correspondingly, the “mild” severity classification may
help to identify which adolescents are apt to achieve improved attitu-
dinal outcomes after the standard course of existing EBTs. Such
understanding may aid in establishing expectations for families and cli-
nicians when planning treatment.
4.1 | Limitations
Several limitations should be noted. This study included self-report of
baseline behavior over the prior 3 months; while the EDE is a widely
used assessment approach, accuracy of symptom frequency may be
impaired by poor recall. Further, given the demographics of this study
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population, we are unable to comment on how these patterns may dif-
fer across gender. Our investigation focused specifically on ED related
outcomes; future work might investigate the impact of severity on
other relevant clinical features (e.g., quality of life; treatment course
and attrition). Finally, with limited sample size that rendered further
divisions inadvisable for reasons of retaining statistical power, this
study did not focus on outcome based on treatment type; future stud-
ies should investigate the potential differential response to different
EBTs based on baseline severity classification. While the present study
focuses on adolescents with BN, there may be benefit to evaluating
severity classifications in other adolescent transdiagnostic samples
(e.g., individuals with anorexia nervosa, who also endorse purging).
4.2 | Conclusions
Severity classification based on frequency of pretreatment behavioral
symptoms predicts a linear trend in attitudinal severity but not behav-
ioral symptom frequency at the conclusion of outpatient treatment
for adolescents with BN. At 6-month follow-up, severity categories
predicted attitudinal symptoms, as well as a significant trend in these
characteristics, but not at later assessment. These findings suggest
that specifiers may have enhanced utility in predicating attitudinal
outcomes over only a limited amount of time following treatment.
Adaptations to existing EBT approaches may be necessary to help
some individuals presenting to treatment with extreme compensatory
behavior achieve behavioral symptom remission.
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